Onconova announces rigosertib poster selected for AACR 2024
PremiumThe FlyOnconova announces rigosertib poster selected for AACR 2024
7M ago
Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024
Premium
Press Releases
Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024
7M ago
ONTX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ONTX Earnings this Week: How Will it Perform?
7M ago
Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
PremiumPress ReleasesOnconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
10M ago
Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results
Premium
Press Releases
Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results
10M ago
Onconova reports Q3 EPS (23c), consensus (29c)
Premium
The Fly
Onconova reports Q3 EPS (23c), consensus (29c)
10M ago
Onconova appoints Moyo as CMO, Arora as VP, Global Medical Affairs, R&D
PremiumThe FlyOnconova appoints Moyo as CMO, Arora as VP, Global Medical Affairs, R&D
11M ago
Onconova announces preclinical Narazaciclib data presented at MCL meeting
Premium
The Fly
Onconova announces preclinical Narazaciclib data presented at MCL meeting
11M ago
Promising Preclinical Narazaciclib Data Presented at MCL Meeting
Premium
Press Releases
Promising Preclinical Narazaciclib Data Presented at MCL Meeting
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100